2 completed, 2 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 2 |
Follow Retinal Artery Occlusion: new trials by email Literature Review of Retinal Artery Occlusion trials Research Report on Retinal Artery Occlusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion Tenecteplase (until trial protocol V04: Alteplase) - Central Retinal Artery Occlusion | Phase 3 | Terminated | University Hospital Tuebingen | 127 | 2022-10-10 | 2026-05-18 |
| TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) Intravenous injection of Tenecteplase and one dose of placebo tablet, One tablet of Acetylsalicylic Acid and one dose of IV placebo - Central Retinal Artery Occlusion | Phase 3 | Completed | Oslo University Hospital | 81 | 2020-10-30 | 2025-09-29 |
| A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion Alteplase, acetylsalicylic acid, Placebo Oral Tablet - Central Retinal Artery Occlusion | Phase 3 | Completed | Nantes University Hospital | 70 | 2018-06-08 | 2024-01-24 |
| EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye Intravenous injection of heparin, Intravenous injection of acetazolamide, Local intra-arterial fibrinolysis - Retinal Artery Occlusion, Fibrinolysis | Phase 3 | Terminated | University Hospital Freiburg | 84 | 2002-09-01 | 2008-03-18 |
Stroke (1)
Arterial Occlusive Diseases (4) · Cardiovascular Diseases (4) · Eye Diseases (4) · Retinal Diseases (4) · Vascular Diseases (4) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Nervous System Diseases (1)
Aspirin (3) · Tenecteplase (2) · Tissue Plasminogen Activator (1)
Nantes University Hospital (1) · Oslo University Hospital (1) · University Hospital Freiburg (1) · University Hospital Tuebingen (1)
Germany (2) · Austria (1) · Belgium (1) · Denmark (1) · Finland (1) · France (1) · Lithuania (1) · Norway (1) · Sweden (1) · Switzerland (1)
Martin Schumacher, Professor (1)
PMID 26349479, PMID 39614619, PMID 41109232, PMID 41604638
2018 (1)